Catalyst Pharmaceuticals Inc (CPRX)

Cash ratio

Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Cash and cash equivalents US$ in thousands 517,553 137,636 298,395 171,445 130,237
Short-term investments US$ in thousands — — 0 19,821 10,041
Total current liabilities US$ in thousands 120,678 76,063 57,588 27,063 22,756
Cash ratio 4.29 1.81 5.18 7.07 6.16

December 31, 2024 calculation

Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($517,553K + $—K) ÷ $120,678K
= 4.29

The cash ratio of Catalyst Pharmaceuticals Inc has shown fluctuations over the years. From December 31, 2020, to December 31, 2022, the cash ratio remained relatively healthy, indicating the company's ability to cover its short-term liabilities with its readily available cash. However, there was a significant decrease in the cash ratio as of December 31, 2023, suggesting a potential need for the company to manage its cash resources more effectively. By December 31, 2024, the cash ratio improved but remained below the levels seen in the earlier years. Overall, the trend in the cash ratio reflects variability in the company's liquidity position over the period under consideration.